High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

Clinical trial NCT01757275 · COMPLETED

Trial details

NCT number: NCT01757275
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bleeding Peptic Ulcer

Start date: 2013-02-01
Primary completion: 2014-12-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.